1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Ottiger, M.
Zerbe, O.
Guntert, P.
Wuthrich, K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
272
64
81
10.1006/jmbi.1997.1220
9299338
The NMR solution conformation of unligated human cyclophilin A.
1997
10.2210/pdb1oca/pdb
pdb_00001oca
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
18036.504
CYCLOPHILIN A
5.2.1.8
1
man
polymer
no
no
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG
EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD
CGQLE
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG
EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD
CGQLE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
T-CELL (JURKAT)
CYCLOPHILIN
9606
Homo sapiens
CYCLOPHILIN
562
Escherichia coli
W3110CI
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-11-19
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-07-07
REL
REL
LEAST RESTRAINT VIOLATION
50
20
NOESY
HNHB
HSQC
CBCA (CO)NH
CT-HNCA
HCCH-TOCSY
CT-HCCH-COSY
CCH-TOCSY
CLEAN-TOCSY
HMBC
(HB)CB(CGCD)HD
HB(CBCGCD)HD
TOCSY-RELAYED-CT-HMQC
6.5
299
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
distance geometry
WUTHRICH
refinement
OPAL
structure solution
DIANA
750
Varian
UNITYPLUS 750
600
Bruker
AMX600
MET
1
n
1
MET
1
A
VAL
2
n
2
VAL
2
A
ASN
3
n
3
ASN
3
A
PRO
4
n
4
PRO
4
A
THR
5
n
5
THR
5
A
VAL
6
n
6
VAL
6
A
PHE
7
n
7
PHE
7
A
PHE
8
n
8
PHE
8
A
ASP
9
n
9
ASP
9
A
ILE
10
n
10
ILE
10
A
ALA
11
n
11
ALA
11
A
VAL
12
n
12
VAL
12
A
ASP
13
n
13
ASP
13
A
GLY
14
n
14
GLY
14
A
GLU
15
n
15
GLU
15
A
PRO
16
n
16
PRO
16
A
LEU
17
n
17
LEU
17
A
GLY
18
n
18
GLY
18
A
ARG
19
n
19
ARG
19
A
VAL
20
n
20
VAL
20
A
SER
21
n
21
SER
21
A
PHE
22
n
22
PHE
22
A
GLU
23
n
23
GLU
23
A
LEU
24
n
24
LEU
24
A
PHE
25
n
25
PHE
25
A
ALA
26
n
26
ALA
26
A
ASP
27
n
27
ASP
27
A
LYS
28
n
28
LYS
28
A
VAL
29
n
29
VAL
29
A
PRO
30
n
30
PRO
30
A
LYS
31
n
31
LYS
31
A
THR
32
n
32
THR
32
A
ALA
33
n
33
ALA
33
A
GLU
34
n
34
GLU
34
A
ASN
35
n
35
ASN
35
A
PHE
36
n
36
PHE
36
A
ARG
37
n
37
ARG
37
A
ALA
38
n
38
ALA
38
A
LEU
39
n
39
LEU
39
A
SER
40
n
40
SER
40
A
THR
41
n
41
THR
41
A
GLY
42
n
42
GLY
42
A
GLU
43
n
43
GLU
43
A
LYS
44
n
44
LYS
44
A
GLY
45
n
45
GLY
45
A
PHE
46
n
46
PHE
46
A
GLY
47
n
47
GLY
47
A
TYR
48
n
48
TYR
48
A
LYS
49
n
49
LYS
49
A
GLY
50
n
50
GLY
50
A
SER
51
n
51
SER
51
A
CYS
52
n
52
CYS
52
A
PHE
53
n
53
PHE
53
A
HIS
54
n
54
HIS
54
A
ARG
55
n
55
ARG
55
A
ILE
56
n
56
ILE
56
A
ILE
57
n
57
ILE
57
A
PRO
58
n
58
PRO
58
A
GLY
59
n
59
GLY
59
A
PHE
60
n
60
PHE
60
A
MET
61
n
61
MET
61
A
CYS
62
n
62
CYS
62
A
GLN
63
n
63
GLN
63
A
GLY
64
n
64
GLY
64
A
GLY
65
n
65
GLY
65
A
ASP
66
n
66
ASP
66
A
PHE
67
n
67
PHE
67
A
THR
68
n
68
THR
68
A
ARG
69
n
69
ARG
69
A
HIS
70
n
70
HIS
70
A
ASN
71
n
71
ASN
71
A
GLY
72
n
72
GLY
72
A
THR
73
n
73
THR
73
A
GLY
74
n
74
GLY
74
A
GLY
75
n
75
GLY
75
A
LYS
76
n
76
LYS
76
A
SER
77
n
77
SER
77
A
ILE
78
n
78
ILE
78
A
TYR
79
n
79
TYR
79
A
GLY
80
n
80
GLY
80
A
GLU
81
n
81
GLU
81
A
LYS
82
n
82
LYS
82
A
PHE
83
n
83
PHE
83
A
GLU
84
n
84
GLU
84
A
ASP
85
n
85
ASP
85
A
GLU
86
n
86
GLU
86
A
ASN
87
n
87
ASN
87
A
PHE
88
n
88
PHE
88
A
ILE
89
n
89
ILE
89
A
LEU
90
n
90
LEU
90
A
LYS
91
n
91
LYS
91
A
HIS
92
n
92
HIS
92
A
THR
93
n
93
THR
93
A
GLY
94
n
94
GLY
94
A
PRO
95
n
95
PRO
95
A
GLY
96
n
96
GLY
96
A
ILE
97
n
97
ILE
97
A
LEU
98
n
98
LEU
98
A
SER
99
n
99
SER
99
A
MET
100
n
100
MET
100
A
ALA
101
n
101
ALA
101
A
ASN
102
n
102
ASN
102
A
ALA
103
n
103
ALA
103
A
GLY
104
n
104
GLY
104
A
PRO
105
n
105
PRO
105
A
ASN
106
n
106
ASN
106
A
THR
107
n
107
THR
107
A
ASN
108
n
108
ASN
108
A
GLY
109
n
109
GLY
109
A
SER
110
n
110
SER
110
A
GLN
111
n
111
GLN
111
A
PHE
112
n
112
PHE
112
A
PHE
113
n
113
PHE
113
A
ILE
114
n
114
ILE
114
A
CYS
115
n
115
CYS
115
A
THR
116
n
116
THR
116
A
ALA
117
n
117
ALA
117
A
LYS
118
n
118
LYS
118
A
THR
119
n
119
THR
119
A
GLU
120
n
120
GLU
120
A
TRP
121
n
121
TRP
121
A
LEU
122
n
122
LEU
122
A
ASP
123
n
123
ASP
123
A
GLY
124
n
124
GLY
124
A
LYS
125
n
125
LYS
125
A
HIS
126
n
126
HIS
126
A
VAL
127
n
127
VAL
127
A
VAL
128
n
128
VAL
128
A
PHE
129
n
129
PHE
129
A
GLY
130
n
130
GLY
130
A
LYS
131
n
131
LYS
131
A
VAL
132
n
132
VAL
132
A
LYS
133
n
133
LYS
133
A
GLU
134
n
134
GLU
134
A
GLY
135
n
135
GLY
135
A
MET
136
n
136
MET
136
A
ASN
137
n
137
ASN
137
A
ILE
138
n
138
ILE
138
A
VAL
139
n
139
VAL
139
A
GLU
140
n
140
GLU
140
A
ALA
141
n
141
ALA
141
A
MET
142
n
142
MET
142
A
GLU
143
n
143
GLU
143
A
ARG
144
n
144
ARG
144
A
PHE
145
n
145
PHE
145
A
GLY
146
n
146
GLY
146
A
SER
147
n
147
SER
147
A
ARG
148
n
148
ARG
148
A
ASN
149
n
149
ASN
149
A
GLY
150
n
150
GLY
150
A
LYS
151
n
151
LYS
151
A
THR
152
n
152
THR
152
A
SER
153
n
153
SER
153
A
LYS
154
n
154
LYS
154
A
LYS
155
n
155
LYS
155
A
ILE
156
n
156
ILE
156
A
THR
157
n
157
THR
157
A
ILE
158
n
158
ILE
158
A
ALA
159
n
159
ALA
159
A
ASP
160
n
160
ASP
160
A
CYS
161
n
161
CYS
161
A
GLY
162
n
162
GLY
162
A
GLN
163
n
163
GLN
163
A
LEU
164
n
164
LEU
164
A
GLU
165
n
165
GLU
165
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
THR
157
A
O
THR
157
A
N
ALA
11
A
N
ALA
11
A
O
VAL
6
A
O
VAL
6
A
N
PHE
22
A
N
PHE
22
A
O
SER
21
A
O
SER
21
A
N
GLU
134
A
N
GLU
134
A
O
VAL
127
A
O
VAL
127
A
N
MET
100
A
N
MET
100
A
O
SER
99
A
O
SER
99
A
N
PHE
113
A
N
PHE
113
A
O
PHE
112
A
O
PHE
112
A
N
GLY
64
A
N
GLY
64
A
O
MET
61
A
O
MET
61
A
N
ILE
57
A
N
ILE
57
1
A
A
HG1
OE2
THR
GLU
116
143
1.51
1
A
A
HG1
OE1
THR
GLU
5
23
1.56
1
A
A
O
HG
GLY
SER
47
51
1.57
2
A
A
HG1
OE2
THR
GLU
116
143
1.52
3
A
A
HG1
OE2
THR
GLU
116
143
1.57
3
A
A
HG1
OE2
THR
GLU
32
86
1.58
4
A
A
HG1
OE1
THR
GLU
116
143
1.54
4
A
A
HG1
OE1
THR
GLU
32
86
1.60
6
A
A
HG1
OE2
THR
GLU
116
143
1.55
6
A
A
HG1
O
THR
LYS
152
154
1.55
7
A
A
HG1
OE2
THR
GLU
32
86
1.57
8
A
A
HG1
OE2
THR
GLU
116
143
1.53
8
A
A
OE1
HH
GLU
TYR
34
79
1.58
8
A
A
HG1
OE2
THR
GLU
32
86
1.60
10
A
A
HG1
OE1
THR
GLU
5
23
1.51
10
A
A
HG1
OE2
THR
GLU
116
143
1.58
10
A
A
HG
O
SER
GLU
77
81
1.60
11
A
A
HG1
OE2
THR
GLU
116
143
1.52
11
A
A
HG1
OE1
THR
GLU
32
86
1.59
12
A
A
OE1
HH
GLU
TYR
34
79
1.58
12
A
A
HG1
OE2
THR
GLU
116
143
1.58
13
A
A
HG1
OE2
THR
GLU
116
143
1.55
14
A
A
HG1
OE2
THR
GLU
116
143
1.54
15
A
A
HG1
OE1
THR
GLU
116
143
1.52
16
A
A
HG1
O
THR
LYS
152
154
1.60
16
A
A
HG1
OE2
THR
GLU
116
143
1.60
17
A
A
HG1
OE1
THR
GLU
5
23
1.56
17
A
A
HG1
OE2
THR
GLU
116
143
1.58
18
A
A
HG1
OE2
THR
GLU
116
143
1.58
18
A
A
HG
O
SER
GLU
77
81
1.59
18
A
A
OE2
HH
GLU
TYR
34
79
1.60
18
A
A
O
HG
GLY
SER
65
110
1.60
19
A
A
HG1
OE2
THR
GLU
116
143
1.57
20
A
A
HG1
OE2
THR
GLU
116
143
1.53
20
A
A
HG1
OE2
THR
GLU
32
86
1.57
19
A
A
MET
VAL
1
2
-142.97
1
A
PHE
36
0.088
SIDE CHAIN
1
A
ARG
69
0.086
SIDE CHAIN
1
A
ARG
144
0.086
SIDE CHAIN
2
A
ARG
37
0.105
SIDE CHAIN
2
A
ARG
55
0.105
SIDE CHAIN
3
A
ARG
37
0.077
SIDE CHAIN
3
A
ARG
55
0.115
SIDE CHAIN
4
A
TYR
48
0.094
SIDE CHAIN
5
A
ARG
19
0.096
SIDE CHAIN
5
A
ARG
55
0.106
SIDE CHAIN
5
A
ARG
69
0.102
SIDE CHAIN
5
A
PHE
112
0.089
SIDE CHAIN
6
A
ARG
55
0.159
SIDE CHAIN
7
A
ARG
69
0.082
SIDE CHAIN
8
A
TYR
48
0.078
SIDE CHAIN
9
A
TYR
48
0.065
SIDE CHAIN
9
A
ARG
55
0.094
SIDE CHAIN
10
A
ARG
19
0.106
SIDE CHAIN
10
A
TYR
48
0.186
SIDE CHAIN
10
A
ARG
69
0.082
SIDE CHAIN
11
A
TYR
48
0.074
SIDE CHAIN
11
A
ARG
144
0.081
SIDE CHAIN
12
A
ARG
19
0.085
SIDE CHAIN
12
A
TYR
48
0.077
SIDE CHAIN
12
A
ARG
69
0.152
SIDE CHAIN
12
A
PHE
112
0.095
SIDE CHAIN
13
A
TYR
48
0.120
SIDE CHAIN
13
A
ARG
55
0.122
SIDE CHAIN
14
A
TYR
48
0.075
SIDE CHAIN
16
A
TYR
48
0.068
SIDE CHAIN
17
A
ARG
55
0.105
SIDE CHAIN
17
A
ARG
69
0.095
SIDE CHAIN
19
A
ARG
19
0.078
SIDE CHAIN
19
A
ARG
69
0.078
SIDE CHAIN
20
A
ARG
19
0.080
SIDE CHAIN
20
A
PHE
36
0.093
SIDE CHAIN
6
-5.33
0.60
121.00
115.67
A
A
A
CB
CG
CD2
TYR
TYR
TYR
48
48
48
N
8
-5.73
0.90
118.30
112.57
A
A
A
CB
CG
OD2
ASP
ASP
ASP
13
13
13
N
12
-3.91
0.60
121.00
117.09
A
A
A
CB
CG
CD2
TYR
TYR
TYR
48
48
48
N
13
-3.90
0.60
121.00
117.10
A
A
A
CB
CG
CD2
TYR
TYR
TYR
48
48
48
N
14
-4.24
0.60
121.00
116.76
A
A
A
CB
CG
CD2
TYR
TYR
TYR
48
48
48
N
15
-3.93
0.60
121.00
117.07
A
A
A
CB
CG
CD2
TYR
TYR
TYR
48
48
48
N
1
A
ASP
13
55.43
13.76
1
A
CYS
52
62.94
174.59
1
A
PHE
60
-135.84
-79.89
1
A
HIS
70
-152.27
34.32
1
A
ASN
71
-150.72
12.18
1
A
LYS
82
48.38
161.41
1
A
ASN
106
39.14
48.17
1
A
SER
110
-156.22
-5.59
1
A
LYS
118
-64.64
91.96
1
A
PHE
129
-140.76
-0.70
1
A
SER
147
-146.47
-61.51
1
A
ARG
148
141.75
-38.60
2
A
PHE
25
-69.61
52.71
2
A
PHE
60
-142.03
-62.96
2
A
ARG
69
-117.11
-165.90
2
A
HIS
70
-174.22
46.83
2
A
ASN
71
-166.85
20.82
2
A
GLU
81
62.17
-133.63
2
A
ALA
101
-95.00
50.92
2
A
SER
110
-142.21
-47.13
2
A
THR
119
-117.67
72.77
2
A
LYS
125
-135.53
-40.31
2
A
PHE
129
-145.30
-3.83
3
A
VAL
2
48.15
-172.95
3
A
ASP
13
56.07
14.03
3
A
CYS
52
113.90
161.91
3
A
PHE
60
-140.64
-80.36
3
A
PHE
67
-58.52
40.10
3
A
THR
68
-148.39
-12.96
3
A
HIS
70
-169.94
45.21
3
A
ASN
71
-155.45
-7.33
3
A
THR
73
-91.52
-96.01
3
A
GLU
81
-91.58
-139.32
3
A
ALA
103
-146.00
36.49
3
A
THR
119
-81.03
42.22
4
A
ASP
13
53.68
13.37
4
A
PHE
60
-137.37
-78.72
4
A
THR
68
-125.65
-58.39
4
A
ARG
69
-103.94
-158.37
4
A
HIS
70
-168.34
41.04
4
A
ASN
71
-122.94
-51.59
4
A
GLU
81
34.48
-133.82
4
A
ASN
102
-76.59
-169.88
4
A
ASN
106
34.16
53.02
4
A
THR
107
-140.63
23.29
4
A
SER
110
-147.06
-39.87
4
A
THR
119
-74.10
43.40
4
A
SER
147
-137.80
-70.36
4
A
ARG
148
143.44
-29.28
5
A
ASP
13
50.88
12.94
5
A
LYS
49
-59.28
101.71
5
A
CYS
52
105.39
161.32
5
A
PHE
60
-138.90
-78.29
5
A
THR
68
-121.83
-50.72
5
A
ARG
69
-106.29
-149.23
5
A
HIS
70
-171.19
69.36
5
A
ASN
71
-165.60
-77.12
5
A
THR
73
-83.60
-73.47
5
A
ASP
85
-67.67
89.27
5
A
ASN
102
-68.34
-179.25
5
A
THR
107
-92.14
39.58
5
A
LYS
118
-66.92
96.22
5
A
SER
147
-143.63
-103.30
5
A
ARG
148
-153.70
-27.03
6
A
VAL
2
50.66
-173.40
6
A
ASP
13
54.72
14.04
6
A
PHE
60
-122.90
-75.98
6
A
ASP
66
-84.45
46.21
6
A
ARG
69
-125.06
-139.12
6
A
HIS
70
-170.06
23.49
6
A
GLU
81
33.79
-142.10
6
A
ASN
108
-66.29
-154.29
6
A
THR
119
-92.98
58.45
7
A
ASN
3
-36.34
112.40
7
A
PRO
16
-66.95
99.20
7
A
PHE
60
-140.67
-81.26
7
A
PHE
67
-96.29
35.70
7
A
THR
68
-155.00
-67.07
7
A
ASN
71
-167.00
4.70
7
A
LYS
82
63.40
158.25
7
A
ASN
102
-69.26
-179.05
7
A
SER
110
-155.74
-21.68
7
A
PHE
129
-140.74
-0.22
8
A
VAL
2
50.12
-173.11
8
A
PHE
25
-81.13
49.54
8
A
CYS
52
122.85
167.73
8
A
PHE
60
-129.11
-75.57
8
A
THR
68
-139.15
-35.41
8
A
ASN
71
-164.51
-54.05
8
A
LYS
82
52.31
149.88
8
A
ASN
102
-165.38
-169.10
8
A
ASN
106
34.18
51.04
8
A
THR
107
-140.63
13.92
8
A
ASN
108
-57.79
96.61
8
A
SER
110
-156.29
-17.43
8
A
THR
119
-114.21
56.88
8
A
LYS
125
-138.91
-45.11
9
A
ASP
13
58.71
17.96
9
A
PHE
25
-68.97
61.37
9
A
CYS
52
86.00
164.93
9
A
PHE
60
-146.93
-81.89
9
A
PHE
67
-63.34
1.25
9
A
THR
68
-139.21
-69.08
9
A
HIS
70
-148.25
33.77
9
A
ASN
71
-144.96
16.27
9
A
LYS
76
170.69
-177.34
9
A
GLU
81
-76.24
-133.51
9
A
ASN
106
44.93
14.70
9
A
SER
110
-144.34
-11.25
9
A
CYS
115
-66.68
94.42
9
A
LYS
125
-144.25
-34.33
10
A
VAL
2
-65.86
-174.26
10
A
ASN
3
-27.94
99.98
10
A
ASP
13
54.24
13.69
10
A
PHE
60
-153.55
-79.23
10
A
PHE
67
-33.37
-18.02
10
A
HIS
70
-156.17
44.03
10
A
ASN
71
-140.34
-8.36
10
A
SER
77
-89.63
35.20
10
A
ILE
78
42.10
-3.14
10
A
GLU
81
-68.50
-132.91
10
A
PHE
129
-150.24
1.18
10
A
SER
147
-146.14
-81.86
10
A
ARG
148
169.06
-21.41
11
A
CYS
52
67.11
132.81
11
A
PHE
60
-143.13
-81.36
11
A
ASN
71
-140.78
10.14
11
A
GLU
81
-68.82
-156.22
11
A
ASN
87
159.07
157.58
11
A
LYS
118
-64.69
84.87
11
A
LYS
125
-132.22
-56.97
12
A
ASP
13
56.62
13.95
12
A
LYS
49
-52.49
108.91
12
A
CYS
52
60.18
176.58
12
A
PHE
60
-150.32
-76.44
12
A
HIS
70
-164.53
54.00
12
A
ASN
71
-159.08
-1.29
12
A
GLU
81
37.25
-133.50
12
A
ASN
106
33.61
54.77
12
A
SER
110
-155.92
-30.97
12
A
LYS
118
-67.51
89.17
12
A
LYS
125
-140.11
-35.00
13
A
ASP
13
57.04
13.92
13
A
LYS
28
-130.45
-47.89
13
A
PHE
60
-142.40
-79.93
13
A
HIS
70
-159.80
72.01
13
A
ASN
71
-168.79
-10.26
13
A
GLU
81
-147.72
-139.26
13
A
ALA
101
-97.08
57.12
13
A
ASN
106
34.56
47.27
13
A
LYS
118
-67.86
89.82
13
A
SER
147
-141.62
-86.51
13
A
ARG
148
178.14
-17.40
14
A
VAL
2
63.89
175.46
14
A
ASP
13
57.32
13.94
14
A
PHE
60
-150.89
-74.02
14
A
PHE
67
-41.16
-2.36
14
A
ASN
71
-173.45
-22.94
14
A
GLU
81
-135.13
-157.61
14
A
ASN
102
-65.98
-178.18
14
A
ASN
106
34.21
57.27
14
A
SER
110
-151.01
-13.12
14
A
LYS
118
-65.52
88.45
15
A
VAL
2
48.16
-173.65
15
A
ASP
13
58.35
13.82
15
A
PHE
25
-69.04
59.11
15
A
PHE
60
-133.11
-72.89
15
A
THR
68
-140.03
-51.68
15
A
ASN
71
-154.07
2.95
15
A
SER
77
-71.45
23.16
15
A
ILE
78
46.29
-19.13
15
A
GLU
81
41.23
-132.80
15
A
ALA
101
-102.09
59.22
15
A
ALA
103
-147.82
19.84
15
A
LYS
118
-67.83
92.10
16
A
ASN
3
-44.97
109.19
16
A
LYS
44
-67.59
2.49
16
A
CYS
52
130.14
144.28
16
A
PHE
60
-133.94
-79.61
16
A
THR
68
-137.16
-45.95
16
A
HIS
70
54.25
12.96
16
A
LYS
76
-170.58
-178.84
16
A
LYS
82
67.38
148.42
16
A
THR
107
-142.25
41.74
16
A
SER
147
-142.18
-72.06
16
A
ARG
148
140.67
-27.39
17
A
VAL
2
46.65
-172.70
17
A
PHE
60
-136.57
-75.64
17
A
HIS
70
-145.11
53.81
17
A
ASN
71
-152.91
-67.37
17
A
GLU
81
34.06
-133.80
17
A
SER
110
-144.54
-13.76
17
A
LYS
118
-68.59
89.85
17
A
LYS
125
-127.22
-52.01
17
A
SER
147
-142.59
-96.05
17
A
ARG
148
-162.20
-23.40
18
A
VAL
2
-69.11
-174.26
18
A
ASN
3
-33.83
104.79
18
A
ASP
13
53.50
13.76
18
A
LYS
28
-145.82
-25.25
18
A
CYS
52
56.38
175.99
18
A
PHE
60
-125.10
-83.89
18
A
THR
68
-136.60
-31.57
18
A
ASN
71
-147.04
-27.52
18
A
SER
77
-84.89
44.93
18
A
ILE
78
49.27
-43.59
18
A
GLU
81
-127.84
-133.23
18
A
ASN
87
167.72
156.42
18
A
ALA
101
-77.62
41.79
18
A
ASN
106
48.85
24.43
18
A
LYS
118
-66.54
93.22
18
A
LYS
125
-137.04
-51.91
19
A
VAL
2
52.42
179.35
19
A
ASP
13
57.44
13.07
19
A
CYS
52
47.11
170.29
19
A
PHE
60
-134.56
-76.29
19
A
THR
68
-139.29
-60.66
19
A
ASN
71
-162.46
-0.90
19
A
SER
77
-73.74
22.57
19
A
ILE
78
49.16
-22.39
19
A
GLU
81
50.10
-132.57
19
A
ASN
106
37.67
43.91
19
A
SER
110
-145.77
33.88
19
A
LYS
118
-68.47
96.42
20
A
ASN
3
-29.08
98.24
20
A
ASP
13
58.68
14.39
20
A
LYS
44
-68.06
1.62
20
A
CYS
52
106.76
144.64
20
A
PHE
60
-143.07
-68.80
20
A
THR
68
-122.98
-67.91
20
A
HIS
70
60.45
-3.81
20
A
GLU
81
-132.44
-137.80
20
A
ASN
106
33.62
48.71
20
A
SER
110
-146.50
-28.86
20
A
THR
119
-74.87
40.67
HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES
1
Y
N
A
PRO
30
A
PRO
30
HELX_P
A
THR
41
A
THR
41
1
1
12
A
GLU
120
A
GLU
120
HELX_P
A
LEU
122
A
LEU
122
5
2
3
A
MET
136
A
MET
136
HELX_P
A
PHE
145
A
PHE
145
1
3
10
ISOMERASE
ISOMERASE, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE
PPIA_HUMAN
UNP
1
1
P62937
VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGE
KFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADC
GQLE
1
164
1OCA
2
165
P62937
A
1
2
165
8
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ILE
156
A
ILE
156
A
GLN
163
A
GLN
163
A
THR
5
A
THR
5
A
VAL
12
A
VAL
12
A
GLU
15
A
GLU
15
A
LEU
24
A
LEU
24
A
VAL
127
A
VAL
127
A
GLU
134
A
GLU
134
A
ILE
97
A
ILE
97
A
MET
100
A
MET
100
A
PHE
112
A
PHE
112
A
CYS
115
A
CYS
115
A
MET
61
A
MET
61
A
GLY
64
A
GLY
64
A
PHE
53
A
PHE
53
A
ILE
57
A
ILE
57
1
P 1